Elleder M, Kmoch S, Hejtmánková M, Bouska I
Ustav dĕdicných poruch metabolismu 1. LF UK a VFN, Praha.
Cesk Patol. 1999 Jul;35(3):98-105.
Basic problems of the group of hereditary mitochondrial beta oxidation (BOX) disorders are presented with evaluation of the role of pathologists in the diagnostic process. The disorders manifest themselves clinically as usual by recurrent Reye-like episodes (acute hepatopathy and encephalopathy) typically in low age levels. Integral part of the clinical picture is often a myopathic symptomatology which at some cases may display even persisting character. The findings at the tissue level are dominated mostly by steatosis of the organ set with a high beta oxidation level (liver, heart, skeletal muscle, kidney) and toxic effects of the intermediate metabolic products of the derranged beta oxidation process. So far eighteen enzyme defects have been described affecting either transport of fatty acids across the mitochondrial membranes or their oxidative degradation at various levels, pointing to an absolute dependence of the final diagnosis on biochemical analysis. Pathologist's conclusion in cases dying without diagnosis is limited to suspicion of a BOX disorder only. However, pathologists can contribute significantly to unraveling and specification of the underlying BOX defect by collecting adequate samples of body fluids and of unfixed organs. Nevertheless, the validity of these samples, even if widely recognized, is limited. The best approach is to provide samples enabling to perform biochemical evaluation of the whole BOX process in integral mitochondrias. This requirement is fulfilled solely by establishing fibroblast tissue culture post mortem.
本文介绍了遗传性线粒体β氧化(BOX)障碍组的基本问题,并评估了病理学家在诊断过程中的作用。这些障碍通常在低年龄段临床上表现为反复发作的类似瑞氏综合征的发作(急性肝病和脑病)。临床症状的一个组成部分往往是肌病症状,在某些情况下可能表现为持续性。组织水平的发现主要以具有高β氧化水平的器官组(肝脏、心脏、骨骼肌、肾脏)的脂肪变性以及紊乱的β氧化过程的中间代谢产物的毒性作用为主。到目前为止,已经描述了18种酶缺陷,这些缺陷影响脂肪酸穿过线粒体膜的转运或其在不同水平的氧化降解,这表明最终诊断绝对依赖于生化分析。对于未经诊断而死亡的病例,病理学家的结论仅限于怀疑BOX障碍。然而,病理学家可以通过收集足够的体液和未固定器官样本,为揭示和明确潜在的BOX缺陷做出重大贡献。尽管如此,这些样本的有效性即使得到广泛认可,也是有限的。最佳方法是提供能够对完整线粒体中的整个BOX过程进行生化评估的样本。这一要求只能通过死后建立成纤维细胞组织培养来满足。